Skip to main content
Contact Us
Subscribe
E-Edition
88°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Vertex Pharmaceuticals Inc
Recent news which mentions Vertex Pharmaceuticals Inc
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
Novo Nordisk A/S
Biotechnology
GSK plc
From
CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
July 08, 2025
Tags
Health & Science
Health care industry
Johnson & Johnson
From
CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
May 02, 2025
Tags
Investment Strategy
Marriott International Inc
NVIDIA Corp
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
GSK plc
Pfizer Inc
Merck & Co Inc
From
CNBC.com News
Jim Cramer says 'the market may be far healthier than we think.' Here's why
March 27, 2025
Tags
Business
Vertex Pharmaceuticals Inc
Amerisourcebergen Corp
From
CNBC.com News
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
February 21, 2025
Tags
Vertex Pharmaceuticals Inc
Business
Business News
From
CNBC.com News
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
February 18, 2025
Tags
Vertex Pharmaceuticals Inc
Business
Health care industry
From
CNBC.com News
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
January 30, 2025
Tags
Health care industry
Companies
Health & Science
From
CNBC.com News
Cramer's Lightning Round: 'I would be a seller of QuantumScape'
January 08, 2025
Tags
stocks
Investing
Serve Robotics Inc
From
CNBC.com News
Cramer's Lightning Round: Vertex Pharmaceuticals is a buy
October 30, 2024
Tags
Stock markets
Investment Strategy
Mad Money
From
CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags
Fulcrum Therapeutics Inc
Agios Pharmaceuticals Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Cramer's Lightning Round: Builders FirstSource 'can go higher'
August 28, 2024
Tags
Market Outlook
Business News
Builders FirstSource Inc
From
CNBC.com News
Cramer's Lighting Round: Vertex Pharmaceuticals is 'terrific'
April 08, 2024
Tags
S&P 500
Sibanye Stillwater Ltd
Business
From
CNBC.com News
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
February 23, 2024
Tags
Social issues
Health Insurance
Vertex Pharmaceuticals Inc
From
CNBC.com News
Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain
January 30, 2024
Tags
Pharmaceuticals
US: News
CRISPR Therapeutics AG
From
CNBC.com News
Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results
December 13, 2023
Tags
US: News
Pharmaceuticals
CRISPR Therapeutics AG
From
CNBC.com News
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
December 08, 2023
Tags
Government Agencies
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
December 07, 2023
Tags
Health & Science
bluebird bio Inc
Health care industry
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
Valley National Bancorp
CNBC Investing Club: Newsletter
Investment strategy
From
CNBC.com News
20 stocks I'm watching in the market, including Emerson, DoorDash, Royal Caribbean
October 09, 2023
Tags
Vertex Pharmaceuticals Inc
Honeywell International Inc
CNBC Investing Club
From
CNBC.com News
Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'
October 09, 2023
Tags
Markets
Eli Lilly and Co
CNBC Investing Club: Analysis
From
CNBC.com News
Cramer's Lightning Round: Vertex is 'excellent'
October 05, 2023
Tags
Mad Money
Kyndryl Holdings Inc
U/S/ Markets
From
CNBC.com News
Stocks making the biggest moves after hours: Arista Networks, MGM Resorts, Stryker and more
May 01, 2023
Tags
Economy
Stryker Corp
NXP Semiconductors NV
From
CNBC.com News
Stocks making the biggest moves midday: Walgreens, Coinbase, Duolingo, Ralph Lauren and more
November 11, 2022
Tags
Deutsche Bank AG
UBS Group AG
Finance
From
CNBC.com News
Cramer's lightning round: Stay with Vertex Pharmaceuticals
October 27, 2022
Tags
U/S/ Markets
Mad Money
Stock markets
From
CNBC.com News
Stocks making the biggest moves after hours: Amazon, Apple, Pinterest, Intel and more
October 27, 2022
Tags
Breaking news
Amazon/com Inc
Vertex Pharmaceuticals Inc
From
CNBC.com News
Jim Cramer says investors should eye these three tech names in the Nasdaq 100
July 05, 2022
Tags
Constellation Energy Corp
Mad Money
Activision Blizzard Inc
From
CNBC.com News
Cramer's lightning round: I'm sticking with Marvell Technology
June 22, 2022
Tags
EOG Resources Inc
S&P 500
Rocket Companies Inc
From
CNBC.com News
Stocks making the biggest moves midday: Global Payments, Moderna, Activision Blizzard and more
May 02, 2022
Tags
U/S/ Markets
Activision Blizzard Inc
Occidental Petroleum Corp
From
CNBC.com News
Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says
April 04, 2022
Tags
Investment Strategy
Activision Blizzard Inc
Mad Money
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.